AE
Asiri Ediriwickrema
Stanford Medicine, Stanford University, Yale University School of Medicine, Massachusetts Institute of Technology
Research areas: Medicine · Hematology · Acute Myeloid Leukemia Research · Hematopoietic Stem Cell Transplantation · Epigenetics and DNA Methylation
0000-0002-6480-8290
Employment
-
Stanford Medicine Assistant Professor2025 - Present
Education
- 2017 - 2024
-
Yale University School of Medicine MD2009 - 2014
-
Massachusetts Institute of Technology BS in Engineering2004 - 2008
Projects & Funding
Projects & funding information is unavailable.
Publications (38)
- Data from Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save
- Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save
- Supplementary Figure S1-S8 from Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save
- Supplementary Table S1-S4 from Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AML Save
- A single-cell framework identifies functionally and molecularly distinct multipotent progenitors in adult human hematopoiesis Save
- Projecting individualized probabilities of lifetime all-cancer risk Save
- IDENTIFICATION AND CHARACTERIZATION OF NEW MULTIPOTENT PROGENITORS IN ADULT HUMAN HEMATOPOIESIS Save
- Convergent epigenetic evolution drives relapse in acute myeloid leukemia. Save
- CD38 and BCL2 expression guides treatment with daratumumab and venetoclax in tagraxofusp-refractory blastic plasmacytoid dendritic cell neoplasm (BPDCN) featuring dynamic loss of CD123. Save
- Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis. Save
- Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity. Save
- Clonal Dynamics and Deterministic Clinical Fate Mapping of Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukemia with TP53 Disruption Save
- Intra-Leukemic IFN. Signaling Mediates Cell Cycle Suppression and Chemoresistance in AML Save
- Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions Save
- Single-cell genomics in AML: extending the frontiers of AML research Save
- Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma Save
- The cell type specific 5hmC landscape and dynamics of healthy human hematopoiesis and TET2-mutant pre-leukemia. Save
- Clinico-genomic profiling and clonal dynamic modeling of TP53-aberrant myelodysplastic syndrome and acute myeloid leukemia Save
- Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells Save
- Single Cell Analysis of Adult Human Hematopoietic Stem and Progenitor Cells Identifies a Novel Lymphoid Primed Multipotent Progenitor That Expands in Relapsed Acute Myeloid Leukemia Save